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INTRODUCTION

Casimir Funk:' a •pooh-ma.king discovery in 1911 that beri-beri
was probably caused b7 a deficiency in the diet of very small amounts
I

ot a substance which

•

he called a •v1tam1ne• (because he considered

1 t essential to lite and thought 1 t to be in the nature

ot an amine)

started off a field of research which has probably never been equled
in scientific histort.

Since Funk's original diacov-er7 tremendous

strides forward have been made in our knowledge of these factors
called vitamin• in a remarkably short time.

However, there still

remains mo.ch to be lf)&rned about the action of these extraordinary
substances in the bo~y before we can really consider our knowledge
adequate, and before: we can successfully combat much of the presentday tad.diem associated with vitamin therap7.

The purpose of this paper is to review the development of our
present knowledge of'! one of these vitamins, nicotinic acid, and to

evaluate, insofar as1 is possible, its efticac7 in the treatment ot
certain clinical com.1 tions.

.il though every medical practitioner

recognizes the value ct nicotinic acid in the treatment of pellagra,

-.ny wbo
I

there are probably

do not realize its importance in the

leH evident ma.nifeatations of deficiency and certainly manJ' who
do not know of its aignificance in body physiology and chemistry.

Much mu.at be left ~ritten at the present time, for our knowledge
of this subst.ance 1• etill in 1 ts infanc7, but inveatigati ve
attention on thia sufbatance is continuing and increasing ao rapidly
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that••

mar

hope for tall clarification ot the subject before

many

7ear1 have paaaed.

Since I have been working with Dr. Sergius Morguli1, Prote,aor
of Jiochemiatry at the Univerait7 of Nebraska.College of Medicine,
on the determination of nicotinic acid in the·blood and urine, I
had. hoped to be able to contribute wome original in:tornation in this

paper.

However, our work haa not ;vet advanced to the stage where

an7th1ng of clinical 11gn1ficance can be contributed, but I h&Ye
included ao• qgeetione tor improvement• in the chemical a11&7

ot niootinic acid.

3

HISTORICAL RIVIEI

Nlcotinic acid was first prepared. in 1867 by Huber in hie
study of nicotine.

Be obtained a compound which he gave the

formula 06 Hsll>2 by oxidizing nicotine with acid potassium chromate
and aulfurio aoid.

Be characterized this substance correctly as

an acid with a. pJridine ba1e (C5 BsN). (1)

The presence of nico-

tinie acid in biological material was not 1uspected, however, until
SuS'Dki, Shimamu.ra, and Odalce isolated it from rice-poliehinga in

the couree of their inveetig&tions on beri-beri and pol,neuritie.(2)
J'tmk independently

ieolated nicotinic acid from both yeast and r1ce-

poliah1nge in 1913 in his attempt to isolate the •vi tamille• which

would prevent bari-beri.(3)

Unfortunately, since inveatigative

attention was at tbat time being focused on ber~ beri, the real
e1gnif1ca.nce of thia d.1ecover7 was not realised, and further work
with nicotinic acid was abandoned when Junk found 1 t to have no

effect in the cure of beri-beri or polyneuritie. (3)

It ia of in-

tereat to note, however, that Funk made the prophetic statement
that there probably existed many- undiscovered vitamins, other than

the anti-ber1-beri vitamin, which might one d.a7 be effective in the
prevention and cure of rickets, acurV7, and pellagra.(4)
Since nicotinic acid ha.a proved to cure pellagra so dramat1c-

all7, and since investigation of the etiology and treatment of pellagra is
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intimately connected with the story of nicotinio acid,

it will be of interest to recount what is known of the history of

pellagra.
J.s far as is known no accurate deacription of pellagra as a

specific disease entity waa presented before 1735.

In fact, the

di1eaae waa probably confuaed with 1curv7, 17Phili1, 8ll4 leproe7.
In 1735 Don G&apar Caaal, plq'a1e1an to Philip T of Spain, wrote a

teecription of

a

serious diaease entit7 which he had recognised

among the peasant• of ~aturia (a province in Spain).
iard, called this condition !!Yll.

41.

a ma

!he Span-

(ro .. aiclm.eae).

J.t

ti rat Caaal mi atook the d.1 aeaae for an atn,ical form of lepro •7
because of ita severe, ravaging effect,, and he called it •acorbutic leproa7•.

Be ao accurately described the akin lesions and

the 41geative and mental disturbances that there is no doubt that

he wa.a dealing with severe forms of what we now call pellagra.

The next report of the existence of this disease in an7

ioua proportion• came from Italy in 1771.

••11-

.lt this time the die-

•••• was reported b7 the Italian ph711cian, J'rapolli, who gave it

the name we now

1118,

pellagra.

The term wa.a derived from the Ital-

ian, pallit HU!: (rough akin), azicl had. been in coJDDOn uae among
the peasant, of Lom'ba.rd7 as their name for thia 41eeaae.

Some Ms.

in from apoiled maize was incriminated aa the cauae of pellagra b7

Lombroao in Italy at about this time.

!hie theor7 gained auch wide

credence t~t in 1776, due to the serious proportions which pellagra
had aeewned, legialation wa.e enacted in Italy

to control the aale

of maize.
!he first ca.ae of pellagra in the United. Sta.tea to be reported
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wa.1 that ot Graf in 1864.

Tyler also reported a case 1n 1864.

Sporadic reports ot pellagra were published after this, but the
1eriouanes1 of the condition waa not realized until 1906 when Dr.

George Searer, then in charge of the Alabama State Boapi tal for .
Inaane l'egroea at Mount Vernon, recognized that an epidemic of a
new and fatal 4ieeaae which had been occurring among the imna.tea
for a 19ar past was, in reality, pellagra.

J'ollowing thia report

there were other reports of outbreaks in varioua state hoapi tale

tor the insane, eapeciall7 in the South, and within a few ;rears
ca.aes had been reported from almost every- state in the Union.
Within the next few years ID&D.7 state pellagra. coumiasiona
were formed, and in 1912 a National Pellagra Conference was called..

In 1913 the United. Sta.tee Public Health Service turned ita attention to the disease and appointed Joseph Goldberger a's head of a

group to inveatiga.te the etiology and the poasibilitiee of cure
and prevention ot pellagra.

I

Although food deficienc7 had. been

euepected a.a the ca.uee of pellagra tor oYer a lmnclred 7eara, and.
although improvement of dietar7 intake, especiall7 as regards meat
and milk, had been the ma.in method of treatment of pellagra ae tar
back a.a the time ot Casal' a original work, 1 t remained tor Gold-

berger to actually prove the theor7 of dietar1 deficiency as the
cause ot pellagra.(4)
..A.a a result

ot experiments on insti tut1onal patients with

pellagra who were cu.red by dieta.r7 change a.lone, and on the experimental production of pellagra. in convicts by diet&JT reatriction,

\

.
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Goldberger postulated hie theory 1n 1916 that an •unbalanced diet,
low in proteina• was the cause ot pel~a.gra.

Be auggested at th11

time that "the incluaion ot treah animal and leg,uninoue protein
tooda in the diet• would prevent pellagra. (5)
hrther evidence w.pporting dieta.r7 deticienc7 a.a the

c&\1.N

ot pellagra began to be aceumlated from animal experimentation.
In 1916 Spencer called attention to the fact that a condition called
black tongu•, occurring aponta.uoualy in dogs, exhibited mark:84
aimilaritiea to pellagra ia hUllllle.(6)

In 1917 Chittenclen and.

Underhill reported the reeul ta ot experimeni&l work on doge began
.•• early aa 1905 in which the7 had

pnl•e4

a e,nd.rome which wae

eimilar to h.umaa pellagra b7 feeding reetri~ted 41eta ot cooked
pea.a, crackermeal,

am. oottonaeed oil. · !hey ezpresaed.

the opinion

_ that the condition • • a deficienc7 di1ease, and wa.a probably ut
cau1ecl b7 a defective nitrogen balaACe, but b7 some dietary factor

auch ae a Titamin.(7)
In 1920 Cary pointed. out the cloae resemblance between the
Chit tend.ea-Underhill a7J1drome and canine black tongue.

B'e claaaecl

black tongue among the deficienc7 dieeaeee and aca,in streaaed the
ailll1larity ot the condition to human pellagra.(8) lheeler, Gol4berger, and Blackatock began their work on the experimental production of black tongue in clogs ia 1922.

They produced the coa-

41 tion b7 feeding reatr1cted diets aimilar to those which bad been
effective in causing experimental pellagra in priaon '90lunteera,

thu.a furnishing further evidence for the common et;ology of canine
\ ..._./

7

I

black tongue and human pellagra. (9)

It is interestirgto note in

this connection that Underhill and Mendel concluded in 1928 that
the Chittenden-Underhill syndrome in dogs was not the ea..'Ile as tbe

experimental black tongue produced by Wheeler and Goldberger.

The7

tound, in fa.ct, that their disease was cured by butter fat, carotene,
and carrots, and concluded that the dietary- factor lacking in their
syndrome was related to the oa.rotenoids, whereas butter tat had
failed to cure Goldberger' a black tongue syndrome. (10)
It was not until 1925 that Goldberger finally abandoned his
theory of protein deficiency as the ca.use of pellagra and e.xpressed
the concept of a •pella.gra,..preventi ve factor• which could be coait
sidered the sole factor necessary for the prevention ot this dis-

ease.

He found, from experiments on pellagrins, that brewer's

7east, milk, and lean beef bad an especially high content of this
factor. (ll)
Further isolation and identification of this npella.gra-preventive factor• was ma.de possible through the discovery that it was a

part of the vitamin B complex, separate and distinct from the antineuritic vitamin.

In February, 1926, Smith a.nd Hendrick found that

there was some factor in 79ast other than the anti-neuritic vitamin
which was easential in nutrition.

This factor withstood autoclav-

ing at 15 pounds pressure tor six hours and was shown not to be a
part ot the yeast protein. (12)

Later in the same month Goldberger

et al reported results of experiments on dogs in which yeast and

lean beef were effective in the cure of black tongue even atter
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L
autoclaving, whereas theae were not effective in the cure of pol7neu.riti1 after the7 had been St1toclave4.

Goldberger 10.gge1te4

that hie •tactor P-P• waa probabl7 related to vitamin B (the antineuri tic vitamin) but • • not destrored b7 autoclaving as wae the
anti-neuritic traction.
uble vita.min

1•.

Be called the entire complex "water-aol-

(13)

!'1- t1ret hint that nicot inic acid might pl&J' an important

part in the bod.7 economy came from the work of Warburg and. Chr11t-

ian on coensJm8 in 1935. when the7 ngge1ted t:bat m.cotinic acicl
amide • • a part of the coen•J'IN molecule. (52)

Jurther work b7

Warburg and Ohrietian aa4 b7 von Bu.ler aacl hie a1aociate1 eetabl i1hed tbe importance of nicotinic acid in biological oxidati~n•.

aa a part of both coens,me I and coens1111 II.

Bo connection-..

tween tbeN aubatanc•s and. the general eubject of pellagr..,J>revention waa 7et realised, however.
In 1935 and. 1936 Eoebn

and.

J:lvehjem

made

a further important

step toward 1he identification of the black tongue-preveattve fac-

tor when the7 ahowd that the tlavina would not cure •chick pellagra• or canine black tonga.e and that 11ver concentrates from

which the flavine had 'been removed b7 a4aorption on fuller' a earth

w~re atill effect 1 w in curing or preventing both ape:nmental
comitiona.

!hey Uxa.a proved that tbe portion ot the B-complex

tha. called ]$a or G ( the heat-stable portion) eont&1ne4 at leaat
two factor•, a flarin am the pellagra,...prevam.tive(or black tonga.epreventive) tactor.(14&, 14b)
j

I

l

I

l
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In the early part ot 1937 :rtmk 8114 hnk: reported that rate

giYen nicotinic acid and e1peciall7 nicotinic acid amine along with
their diet had a larger tood intake~ showed better weight gain
than control, on limilar diets without nicotinic acid or ite am-

14.e. (15)

!hey apparentl7 did not connect this with an7 diaea-

preyenUng power.

In tact, it ia now known that rat, are able to

e111the1ise nicotinlc ac14 in the bo47 and, therefore, are not 11UbJect to the production ot a pellagre-U.ke •Jndro• experiment&ll7. (M)
It • • later in 1937 that ZlvebJe•

am hie co-workers publ11he4

the prelimim.17 report of their now-famn.1 ·work on the flnal ieolatien and identification ot the bl.&clt tongue-preventive tactor.(16)
!her found that aicotinic acid or n1cotinam14e, wben give to •1•

ea a modified Goldberger diet, would cure black tongue Ter7 rap1417
u4 would. •1nta1n growth in theM doga although tm1 oontinud oa

the aame deficient 41et.

Bicotimt.m1de was ieol&ted from liTer, a1Ml

it wae fo=4 that 50 milU.grue of the nicotiumide bad. a ou.ratiTe

ettect on black tongue ....,i to that ot

aoo

grama of fraah liTer.(16,17)

!be prokble 14ent1ty ot m.9ot1nic acid with the pallagra-pre-

Teati ve taotor n.ggeate4 b7 El vehJ•' • 4.iecoTery • • appreciated
almo1t inmed.iatel7 by the •41cal proteasion,

au.

MYeral ll'O'QJ)I

of cl1n1c1ana who were eapeciall7 intereated in pell&cra teated
the ettect of nieotinio acid on pella.grina within a tn •nth•
after Kl.vehJem' a original report.

.All ot theae grou.pa reported

almost miraculous cures ot hllllUl pellagra.

MIOng the tirat to re-

port 1ucce11ful • • ot pellagra with nicotinic acid. were J'oa.te,

\._)

I

'j
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Helmer, Lepkovslt7. aa4 Jukes (18), Smith, Buffin, and Smith (19),
and Spies, Cooper,

am :Bla.nkellho~ (20) The report, of

the work

ot these groups ware followed b7 .a rapid aucceasion of reports of
irmumen.ble cures of pellagra 1f{Uh nicotinic acid, its sodium aa.l t,
. or nicotinic acid amide.
Further work bas been done •1nce on the poaaible uaea of nico-

tinic acid in other conditiona, tta toxic81ty, its place in the

bod.7 econom7, the detection of d•ficiency of nicotinic acid, ancl.
various other aspect,.
the bo47 of thia pa.per.

!hese wifl be taken up in detail later in

ll

CBJ:MIC!L DESCBIPl'ION

Bicotinic acid 11 the simplest of the known vitamins a, regard.a
ita chemical 1tructure.

It it also known aa p,rid1ne-.B.H:-carbos-

7lic acid aud 3-p7rid1necarbox7lic acid..

liecentli', a change in term-

inology baa been w.ggeated b7 a comnittee compoaed of Dr1. Elvehjem,
Sebrell, and Spies.

Thia coumi tte waa appointed by the J'ood am

l'utri tion :Board of the Bat ioml lieaearch Co'UXlcil to adopt a name

for nicotinic acid which would not suggeat ita relationship to nico tine and would., thua, be .-ore su1 table tor commercial uae.

!h.e1e

men 8'1lbmi tted the term• niacin and niacin amide a, alternate• for

nicotinic acid and nicotinic acid amide.

!he nggeeted term, were

accepted for use on commercial product,, but the original terms of
nicotinic acid and nicotinamide are to be retained aa firat choice

for use in ecientific literature.(21)
lficotinic acid ia a mono-carbo:z:7lic acid derivative of pJrid.ine.

Ita empirical formula ia

c6B4 llCOOB.

Its ahltctural formula

and thoae of ita sodium salt and of ita amid.e are repreaente4

graphically in figure 1.

In the po.re etate nicotinic acid occur•

aa colorle11, needle-lib cr7atala or as a white cr7stalline pow-

der with a alightl7 bitter taste.
It melt• between 2M0 am. 237°

in air and ia mt qgroacopic.

o.

Its mol•cular weight ie 123.11.
and ie aublimable.

It ia atable

It is slightl7 eoluble in cold

water or alcohol and is freely eoluble 1n hot water, hot alcohol,
or warm glrcerine.

It ia alao soluble in eolutiona of alkali
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am.

carbonates, alkali h1droxidea,

dilute mineral acids, but 1t ia

J. 1&~urated aolution of n1cotin1c

practically insoluble in. ether.

l'icotinic acid ie ,table at high temp-

acid has a pB of about 4~?.

erature a and may be sterilized b;r autoclaTing witbout 4ecompoaition.

~

/c, o

H-C

~

~

/c, ?i

c-~OHHC

/ '- i

c-c-~

C-C;~

H-t,NJ-H ~NJ-H l"~L
N~TbNJG

NJ~8~\~1TE

NICOTlNAMIDE

J'ig. 1.--Stro.ctural Yoram.l.aa of
•1cot1n1c .&cid &114 I.elated Compound.a

lficotinic acid. amid.a or n1cotinami4e baa tlle apirical form.la

c5B4ICODa

and a molecular weight of 122.12.

!he accepted chemical

name tor this ftballlmce 1a 3-p7!'14ineoarbonm14e.

It ocC\tra ae

fluff7, need.le-lib, wh1 te, odorleea c17etale with a aligb.tl7 bitter

taete.

!he • l ting point

1•

between l.29° and

1a1°c.

It 1 a Ter,

soluble in water and 1D alcohol, but ia onl7 elightl7 eoluble 1a

acetone, ether, b911sen.e, and glycerine.
nico tinamide • • a pB of 5. 9.

ture a below

eo0 c,

.l 2'1, aqueous solution of

Bico tinam14e 1 a atable at tempera-

but it ma.7 deteriorate on upon.re to temperature•

aboTe 5QOc tor long period.a of time.

Prolonged upesun to light

ma7 aleo cauee 4ecompoa1 tion.
81DCe nicotinic acid 1a not ftry eul table tor parenteral ad.mini1tration ite sodium Alt 11 uN4 tor this purpose.

!hi1 a'b-

atance alao occur, aa fluttJr, wh.ite, needle-like crystal, with a

),
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1lightl1 bitter ta.ate.

Solution• ot aodium nicotinate are best

for intra.T~oua a4m1n1atra.t1on because of the great eolubility ot

the au.bats.nee and. because of the 1lightl7 alkaline reaction ot it•
,olutions.

.l l~ solution

ot aodinm nicotinate ba.1 a pB of 7.4, a

l~ solution a pH ot 7.8, and. a 2o,C eo·lution a pl'. ot 8.1. (22,23,24)

1
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M'.l'l'll>DS OF ASS.AT

In 1899 Vongerichten first described a reaction ot certain

pyridine derivative, with 2,4-dinitrochlorobenzene to produce a
aubatance which. on decoq,oai tion b7 amine a or alkali h1d,.roxidea,
7ielded a cleepl7 colored product. (25)

!his reaction waa applied

to the cleterminat1on ot nicotinic acid and nicotinamide b:, Xarrer
and Xeller •

in 1938 after the importance· of t~eae w.batancea in

nutrition waa ma4e apparent.

!he7 fueed 2,4-dinitrochloro·benzen.e

with tbe unkmwn at 90°c tor o.ne hour.
extracted with ether and water,

am.

Then the fused product waa

the wate17 extract, which con-

tained the nicotinic acid and amide, was ma.de alkaline with KOH.

The re811lting colored product was then obaerved in a photoelectric
colorimeter, and the amount of nicotinic acid or nicotinamide wa1
calculated by meana of extinction curves on the colorimeter. (26)
Tilter, Spiea, and Mathew• applied the aa.me method to the

determination of nicotinic acid or 1 ta amide at about the aame

t 1me independently.

.Al.moat the only difference between their

method and that· of lC&rrer and lteller waa the uae of :RaOH in place
of ICDH.

!hey applied the method eapeciall;y to the determination

of p7ricline derivative• in human urine.

They found that nicotin.ic

aalcl and its amide, and possibl7 other pJridine-lilr.e 1ubetancee,

could be determined b7 thia method, but that trigonelline, the
I

chief elimination product ct nicotinic acid, could not. (27)
In 1904

l'lnig described a aomewhat similar reaction to t:bat

15

of Vongerichtan.

Be ebowed that upon reaction

ot various pJri4ine

compounds with c78Dogen bromide, addition compounds were formed
which, after deoompoaition with aromatic amines, yielded colored
products

whoee

color intensity was proportional to the amount ot

p7ridine aubstance uaed.(28)

Swaminatban applied thie reaction to

the determination of nicotinic acid in biological ma.teriala.

Be

firat decolorized an aqueous extract of the aubatance to be teeted.
with lead acetate and charcoal, then added cyanogen bromide and
aniline.

The intenai ty of the resultant ,ellow to 79llow-green

color was then determined b7 meane of a photoel-*ric colorimeter
and the amount of nicot inic acid calculated from preTioua ata:odard.1 za tion of the inatrmnent with known quantities of nicotinic acid.

In determinations on blood Swaminathan first precipitated the blood
proteins by the generallJ-ueed J'olin tungstic ac14 method.

8wam2'-

nathan also ahowed that trigonelline produced no color in thia

procedure. (at~
Melnick and J'ield etudied the same method tor d.etermim.ng
nicotinic acid.

After stud.Jing varioua methoda of preliminar1

purification and decolorization of the aolutiona to be teated. they

recommended the use of preferential charcoal adaorption to decolorize aD1' colored eolution before adding the c7&110gen bromide and

aniline aa the beat procedure. (30)
In 1939 Bandier and Bald deacribed a alightl~ different method

tor the estimation of nicotinic acid.

Colored na.ter1ale were tirat

precipitated b7 acetone (in which nieotinic acid ia eoluble), and:
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then the acetone-aoluble portion was treated with cJ8n()gen breatid.e

and metol (para-metqlam1nophenol aulfa.te) with a reaulting colored
product whose intensity could be determined colorimetrically.

Thi••

autllor1 stated that nicotinic acid amide bad to be h7drol7zed with
NaOR to nicotinic acid before 1 t could be determined b7 their method. (31) .A. rather similar method, using par... aminoacetophenone in-

stead. of aniline or matol to develop the color waa reported b7
Barria and l.a1Dl()nd in 1939.

!hey used thie method onl7 on the

urine.(32)
The method which Dr. Sergiua Morgulis and I have been using

in the determination of nicotinic acid and associated compounds ie
a modifica.t1on of the c7&DOgen brom14.e-am.line method. which had

been worked out b,- Fried.emazm, Barborka, and Haugen w1 thin the pa.at
7ear. (33) We consider thia the best of the methods reported to
4.ate, for it ie not only relatively simple, but it g1vee Yery conaistent reaul ta if carried out carefully.

Furthermore, it detei,.

mines both nicotinic acid itself and all other pyridine compound•
related to nicotinic acid except trigonelline.

fheN varioua com-

pounds a.re h7drol7zed either to nicotinic acid or to 1ome limilar
compound which gives the same color reaction by means of the llCl

used in this procedure.

!rigonelline ia not lqdrol7zed b7 acida.

Briefly the procedure 1 e carried out 1n the following manner.

!o 5 cc. of the blood or urine or to 5 gram, of tiasu.e a.re added
. 5 eo. of water a.nd then 5 cc. of 8 N Bel in a ltjeldabl digestion
tube which is marked at 35 cc.

The contents a.re mixed and the tube
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11 then covered by a glass bulb and plac•4 in a Yigorou117-,01l1Dg

water bath.

'!he digestion 11 continued tor thirty minutes it urine

1a being analJzed, a1it1 minutes in the ca.ae ot blood or tissue.

!he content• are mixed at frequent intervals during the boiling.
Uter the required time the tube is removed and cooled.

!he con-

tent• are taen diluted to about 20 co. with water, and 2 cc. ot

sine eultate are a4ded.

!hen 5 cc. of a 1peciall7 prepared 4 •

llaOB 10lution are added with conatant m1x1n1.

Tm tube ia

again

cooled, and thats. another 5 cc. of the BaOB are added, alowl7 and

with constant m1x1ng with a long, thin, tooted, glaea rod.

!he

tube 1 a again cooled, and a drop of cap17l ic alcohol 1 s added,
~tar which the contents are diluted to 35 cc. with water and

then mixed t~roughl.7.

The material 11 then centrifuged. at high

apeed tor about 10 minutea.

'fhe n.pernatant fluid ahould now be

perfectly clear and 1hould be juat alkaline to phenol red ia.t atill
colorleH to phenolphthalein.

!hie procedure haa now precipi tate4

the protein.a, ha1 adeorbed practically all color (b7

meana of the

zinc h7droxid.e precipitate), and ha.a lq'd.rol71ed all the p7ridine

compound.a except trigonelline to nicoti:nic acid or a nicotinic
aciclr-like compollDd.
!'wo 5 cc. aliq'UCtea are now •anred trom the aupernatant
fluid obtained in the above proceclure.

o rimeter tub• it added 4 cc. of a

i

!'o each of theee in a col-

JI cpnogen bromide eolution

and. l cc. of a 4~ aolution of aniline in abaolute alcohol. - !he

intenai t7 of the resul tent color 1a then determined bJ meane ot
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the Bvel,n photoelectric colorimeter u1ing the 420 tilter.(33)
Dr. Margulis and I have fot1nd that the color is tully developed
within two minutes after adding the aniline and that 1 t remains
stable tor at lea1t one or two minutes thereafter.

We have, there-

:tore, taken our rea41:nga on the colorimeter at either two or three
minutes after addiDg ·the aniline.

We have also found that there

is leas likelihood ot turbidit7 or other disturbing factor• in the

eolution it the material 11 filtered Just after centrifuging, before meaauring the 5 cc. aliquotea tor the actual determination.
The amoimt of nicotinic acid present is calculated by mean,
of a curve previously prepared by using known amoU11ts of nicotinic
acid in the above procedure to stazidardize the colorimeter.

flue

standardisation was done by using five standard solutions ot nico-

tinic acid which were so prepared that the 5 cc. aliquote of each
solution, after the zinc hydroxide precipitation was carried out
as described above, contained, respectively, 2.5, 5.0, 7.5, 10.0,

and 15. 0 microgram• of nicotinic acid.

.l blank procedure wae also

carried out ..- using diatilled water in place ot the unknown to be
analyzed.

By means

ot

the blank the colori•ter waa set at 100,

which aignified the point of lea.at abeorption of light for the

procedure, and thu1 the reading for no nicotinic acid.

Rea.ding,

were then ma.de on the stand.a.rd eolutions after following the procedure previously described, and theae readings were plotted on
••mi-logarithmic graph paper against the known amount• of nicotinic

acid used.

The resultant curve was a straight line. (J'ig. 2)
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!his curve wa.a then uaed to read the amount of nicotinic acid in
a aample trom the amount

ot light abeorbed. after develo:pment ot

the color with C1&ll0gen bromide and aniline.

!hie value waa than

multiplied by 140 tc convert to microgram• per 100 cc.

o

2.S

5:0

7.S'

10.0

ll,S

15.0

NICOTINICACID IN MICROGRAMS

~ig. a.--staudardisation C'IU'Te tor
Bice time .Acid on J:yelJn Pho to-

electric Coloriaeter

I have deecribed thia procedure in detail pur.poael7, tor I
think that 1 t ia not onlJ the simples\ but probabl7 the moat acCUJW

ate ot the varioua chemical metbod• tor determining n1cotim.c acid
in biological material.

If blood or urine levela of niootinic
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acid should prove to be of ·clinical value in diagnosis of deticienc1

atatea, I am sure this method would be easily adaptable for clin:-

ical use.

However, blood and urine nicotinic acid levels ba.ve not

7et been proved to bear 8lJ.1' significant relation to nutritional
atate as I eball bring out in more detail in the following chapter.
I have not yet described a method for determining trigonelline
in the urine.

Thia is obviously of great importance, aa trigonel-

line is the chief elimination product of nicotinic acid.

In 1940

Perlzweig and his aasoeiatea suggested a simple method for determining this eubstance.

They found that if trigonelli:ne was heated

with 6 N KOH at 75°0 in the presence of an anmonium aalt or urea
it could be determined b1' the ordinary cyanogen bromide-metol meth-

od.

These workers obtained a 70'1, 7ield b7 this method. (34 )· The

same procedure can probably be used with the CyazlOgen bromide-analine method or the 2,4-dini trochlorobenzene method if desired.
There are two methods of indirectly- e1tima.ting the amount of
nicotinic acid in biological materials which are fairl7widel7
used.

These both depend on the fact that nicotinic acid 11 found

in the body chiefly as a component of the coen11ffl9s I and II.
'fheee methods measure the amount of coenzyme present a.nd thus,

indirectly-, the amount of n1cotinic acid.
One of these methods is that uaed so extensively by Axelrod
and Elvehjem in their studies on animal tiasues and blood.

Thia

is the so-called J:aleri-K7rbick yea.et fermentation method.

'fhe ~e-

eential procedure is baaed on the fact that the addition of va17ing
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amounts of coenzyme I to special washed yeast preparations will
produce rates of fermentation which are proportional, w1 thin certain l 1mi ta, to ·the amount of co enzyme added.

The co enzyme 1 s e:a;.

tracted b7 placing the tissue in boiling water for two minutee.

The material is centrituged and 0.4

fluid ia used in the determination.

too.a

cc. o:t the 8Upernatant

Thia fluid is added to a mi:&i-

ture of a washed yeast preparation (which, thus, contains all enZJ'!D8• except coens,me I) with a glucose solution, a solution ot

hexoaediphosphate, a magnesium and manganese eolution, and a lofter
1olution.

The rate ot carbon dioxide evolution is measured in a

Barcroft differential reepirometer.

A. standardization curve for

the procedure is prepared b;y ueing known amounte of coenzJ'Dl8 I in

the same procedure.

The unknown ma.7 then be calculated from thie

curve. (35)

The other indirect method tor determining nicotinic acid
through coenzJ1118 estimation depends on the discovery in 1937 b7
Lwoff and Lwoff that a certain factor, which they called factor V,
was neceHary for the proper growth of Hemophilus influenzae and

Hemophilua paraintluenza.e.

!he7 found that coenzymea I and II

were the onl7 known substances which could be shown to have thie
growth-promoting effect on the hemophile group of bacteria.
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other pJTidine derivatives could be substituted.(36)
In 1938 lCol:Ln used this discovery as the basie tor a method of

eat1mat1ng the amount of coenz:,me in blood.

The essentials of the

method a.re that the growth-promoting activit7 of unknown materials
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ia compared to that ot known amounts of eoenzyme on cultures ot
Hemophilus paraintlU8nzae.

!he cultures are compared for the

amount of light absorption(a.nd, thua, indirectl7 tor the number

ot bacteria) in a photoelectric colorimeter after about 24 to 30
houra ot incubation at

37°c. (3?)

Jl though biological a.ssa7 of unknown material.:. b7 observing
the reaponae of definitely deficient animals to whom this material
ha.a been fed ie poaaible with nicotinic acid

a.1

with_all the other

vitamins, this method has not been used very extenaivel7 beo&u.H
of the aimpler chemical methods o! aaaa.7.

El TehJem and hi a associ-

ate, have applied thia method, uaing black tongue dogs, to check
the accurac;y of chemical met:bod1. (40)

OCCTJJlRD'Clt:

la Food.a
Although the f'act tbat nicotinic acid is the pellagr&-prevent-

ive factor has only been established since 1937, the value of ce~
tain foods in preventing a:nd curing pellagra h&a been known tor
man7, many 7ears.

Goldberger found, as early as 1925, · that brewer• a

7eaat, milk, and lean beet were high in content of hil •tactor PP•. (11)

.Actual estimation of nicotinic acid content ot foods b7 chemical or biological assay was not begun until about 1939, more than
a 79ar after the discover, that nieotinie acid was the pellagra-

preventive factor.

The first report of the chemical e:atimation of

nicotinic acid in foodatu:f'fa wae that of Bandier in Jul7, 1939.
He used the CJ&nogen bromide-metol method of estimating nieotinic

acid and found the following amounts of nicotinic acid per 100 grams
of' f'reah material:

5 mgm. in pork and beef muscle, 12 mgm. in pork

and beef' liver, about 15 mgm. in several commercial stoma.ch prep-

arations, about 50 mgm. in several yea.at preparations, and from 30
to 120 mgm. in several comnercial liver preparations and extracta.(38)
In 1940 Xodicek, using Ha.rri s and Ba.~ond.' a cJ'8ll.C)gen bromide-

para,.aminoacetophenone method, found low nicotinic a.aid values for
egg-white and milk and high values for all animal tissues, the
highest of which were found in tlle liver and the adrenal.a.

He

also found high values for several cereals but suggested that th1a

was due to some in terferring su.bstance. (39)
ElY9hi1em and his co-workers' used a biological assa.7 ot nicotinic acid content of foodstuffs b7 determining the amounts of the
variou,· materials needed to cure black tonge in doga on a modified

Goldberger diet.

The7 found, in agreement with m:,st of the more

recent colorimetric me~hods ot determination, that meats, liver e:x:tra.cts, a:nd 19ast were high in nicotinic acid and that wheat-gei,a,
eggs, a:nd milk were low in this substance. (40)
In January, 1941, l3achara.ch reviewed the results obtained with
all the variou1 types ot determinations ot the nicotinic acid content ot foods used by various groups.

lie tound a general consensus

of high values in 79aat, 11 ver, leau meat, fiah, unpolished rice,

and peanuts;

moderatel7 high values in so7-bean, wheat, and barle7;

and. low Taluee in other cereals, dair7 products, and eggs.

Very

complete and len.gtq tables are published with this reYiew. (41)

la ,tni,mtJ Ma.ter1&1-Borm1 !m4. Pathological
Investigation of the nicotinic acid content of animal tissues
baa been spurred on chie:tl7 b7 the desire to find a method tor the

detection of beginning or aubclinical nicotinic acid deficienc7.
Most work haa been

done, therefore, on the blood and urine.

!he normal blood values var7 a great deal with the procedure
uaed.

Swaminathan (29) reported .33 to .35 mgm. nioot1n1c acid ~r

100 cc. of human blood

a, -normal;

reported aa average value ot .367

Kochar, using the aame method,

mgm.%

in normal lmman blood. (42)

Melnick, iobinaon. and Field found an average blood level ot .73
mp. i. (43)

Reports trom various other workers range anJWhere be-

tween these sets of figures.

!he average blood level for a group

ot normal persons as determined

by Dr. Morgulie and me was .558

mgm.~, with T&luea ra:oging from a low of .455 mp.ff, to a high ot
• 648 mgm. '/,, al though moat values were ver7 close to the average

(within about .05 mgm.i).
Melnick and his co-workers found that

9o% ot

nicotinic acid ie present in the errthroc7tes.

the total blood

!J.'hia group re~rted

high values in pol)"'C-ythemia, pre8tlll&bl7 because of the high concentration of e17throc7tee.

!his group also investigated the effect

of varioua other :f'aotore on the blood nicotinic acid level.

The7

found no appreciable effect on ti. blood level following recentl7-

inge1ted meal.a, coffee-drinking, or smoking.

!hey aleo found that

a large oral doee ot nicotinic acid caused a rise in tba blood
level, followed b7 a rapid drop to normal levela.

Repeated doses

of nicotinic acid cauaed an increase in tbe blood level which pel"aiated for a long time after the doaage was atopped.(43)
Bo one haa found a:D1' significant relationahip between nicotinic

acid blood level• and the state ot nutrition.

Xccbar found pell-

agrina to have the aame average as normal persons, and he to\U14 no
riae in the blood levels on treating these patients with nicotinic
acid, although they improved clinicall7. (42)

Using the .Buler-1411'-

•

back 79aet fermentation method Axelrod, Madden, and Elvehjem could

find no decrease in the coenzyme I content of blood, Jdd.ner cortez,
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or bra.in in dogs and pige in whom nicotinic acid de:f'icienc7 had
been produced by use o:t a modified Goldberger diet.

They did, bow-

ever, :tind tbat the coenzyme content of both liver and ma.ecle wae
markedly decreased below the normal in the•• animal 1. (44)

.h:elrod,

lClvehjem, and Spies found a similar situation in human pella.grina.
The coenzJme I content

ot the erythrocytes waa normal in these

pellagrine but was found to be low in muscle tie8128.(•5)
Tilter, Tilter, am Spies reported in 1939 that the V factor
(by the method of Kohn mentioned previoualy) was ma~dl.7 below

normal in the blood ot pellagrina and. eevere diabetica(especiall7
those with acidosis). (46)

Thia is the only report in the 11 tera,.

ture of low blood values ot either n1cot1m.c acid or coenz)"Rle in

pellagrins.

There is, , tu.rthel'ID)re, some overlap in the blood val-

u• et the pellagrous group and those or the normal group in thia
report.

Report• on normal urina.17 values for •n1cotinic acid• are at
great T&riance, chiefly because some methods determine only actual

tree nicotinic acid, ao• determine all tn,ea of p7ridine derivative• except trigonelline, and others determine varioue numbers ot

compo'\lnds between these extremes.

Swaminathan reports a dail7 ex-

cretion of 3 to 5 mgm. ot n1cotin1c acid as determined by his aethod. (29)

(32)

ot

Barria and lla,mond report the same Taluee b7 their method.

Perlzweig, Lev7, and Barett found the normal daily excretion

all p,ridine deri'Yativea except trigonelline to be 1 to 3 mgm.,

and. that of trigonelline to be about 20 to 28 mgm.

!heae author•

2?

found that coffee-drinking increased the trigonelline excretion to

a,

high

a,

200 mgm. da.ily.(47)

There are several reports of finding low nicotinic acid level•
in the urine of hum&n pella.grina and of animals with experimental
nicotinic acid deficiency.

Vilter, Spies, and Mathews reported low

urinary values in pella.grina b7 their method in 1938. (27)

In 1939

Harris and ia.J1DC)nd found that dogs and guinea pigs deprived of nieotinic acid in their diet showed a gradual drop in the excretion
of nicotinic acid which paralleled their clinical condition, until
finally they excreted no nicotinic acid at all when in a state of
severe deficienc7.(32)

Sarett ha.a also very recently reported that

the urinary excretion ot acidr-hydrolysable n1cot1n1c acid deriva-

t 1ves and of trigonelline fell to very low values in dogs in whom
black tongue was produced experimentall7.(48)
Field and his associates reviewed the literature on the chemical diagnosis of nicotinic acid deficiency in July, 1941, and found
no definite relationship between the blood levels of nicotinic acid
or of coenzyme in normal and in deficient individual,.

They also

had little faith in urinary determinations at present, for they

stated that some fraction of nicotine is determined in nicotinic

acid methods, and further, trigonelline, the chief excretor7 product of nicotinic acid, is also found as such in some foods, in
coffee, and as a result of detoxification of nicotine in the

bod7.

They therefore feel that the chemical diagnosis of nicotinic acid
deficiency is thus far wholly unsatisfactory. (49)
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Sarett reported in Januar7, 1942, that although clogs on high
nicotinic acid diet• excreted (as trigonelline and other derivatives) almost 10~ ot doses of nicotinic acid given orally, black
tongue doge did not excrete an7 part of these doses until several

do••• had been given, and even then only excreted part of the dose,.
(48)

Th.11 discovery wa.a applied to hnma.na by Perlsweig, Barett,

and Margolis, who pu.bl1ahe4 a preliminar7 report in J&m:1&r7, 1942,

1tating that the7 found hoapital patients and undernouriahed.JOU,th1
excreted a smaller portion of a large dose of nicotinamide given
or&ll7 than did normal persons.

The7 auggeat this aa a possible

method tor detecting aubclinical 1....,11 of nicotinic acid deticienc7 in man.

Further investigation of the subject will be necee-

aar7 before tull evaluation of the method ia possible.(50)
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BIOCHEMICAL-PHYSIOLOGICAL SIGNIFICANCE,
FATE IN THE BODY, AND REQUIREMENTS

To tell the story of the role nicotinic a.cid plays in the
body economy we must go back to 1906, when Harden and Young reported
their discovery that there was some aubstance in 19a.st which, after
boiling and filtering or dialyzing, could enhance the fermenting

action of yeast, although it could not initiate such fermentation
by itself'.

The term coz,maae was applied to this cryetalloidal,

thermostable substance which was so necessary for the process ot
yeast fermentation.(51)
J.l though much work was done on co z ;sma.se in succeeding years,
it was not until this compound and a closely similar compound were

isolated from animal tissues and found to contain nicotinamide in
1935 and 1936 that the role of nicotinic acid in the biochemico-

physiological processes of the body began to be realized.

!he first

of these substances to be isolated was not identical with Ha.rd.en
and Young' s co zymase but was a closely similar compound which waa
found to be necessary for the oxidation of glucose-6-phoaphata by
an enzyme of mammalian erythrocytes.

This aubsta.nce was isolated

in 1935 by- Warburg and Christian, who called 1 t co enzyme and ob&~
aoterized it as containing one molecule of adenine, one of nicotin-

amide, three ot phosphoric acid, and two of ribose.(52,53)
About a year later Barden and Young's coz~se was isolated

independently by Warburg and Christian (54) and by von Euler, Alber•, and Schlenk. (55)

This compound was also called a co enzyme,
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and, since it was discovered first, was called coenzyme I, while
the coenzyme isolated by Warburg and Christian in 1935 was called
coenzyme II.

Coenqme I contains the same units ae coenzyme II,

except that it has one less molecule of phosphoric acid.

Coenzyme

I is a.lso known as cozymase, di:pbosphopyridinenuclaotide, and DPN.
Coenz1ff18 II is also called triphosphopyridinenucleot14e and TPN.

~
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Fig. 3.--Stru.ctural Formula of
Triphosphopyridinenucleotide

Although the structural formnlas of these two important substances ha.snot been proved definitely, they probably exist as shown
in figure 3.

leotide;

The formola. shown is tha.t of triphosphopyridinenuc-

diphosphop7ridinenucleotide is exactly the same structur-

ally, but it has one lees esterified phosphoric acid group.
As

intimated before, the importance of these eoenzymes lies

in the fact tbat they are necessary for the proper catalytic action
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of certain enz1111es.

Just wha.t part they play was first indicated

by Warburg and Christian in 1935 when they proved that tripho s:pho-

pyridinenucleotide constituted a reversible oxidation-reduction
system and that nicotinic acid amide was the portion which waa actuaJ.11 concerned in this process.

They showed that in the oxidation

of a substrate the nicotinamide group was reduced, the reduction
taking place at the carbon-nitrogen linkage of the p,ridine ring,
the qua.ternarr nitrogen then becoming a. tertiary nitrogen. (53)

The same type of reaction takes place in the case of diphosphopyridinenu.cleotide in its role aa a coenzyme.

This reaction 1a

represented in figure 4, the formw.ae being simplified to show onl7
the groups concerned in the oxidation-reduction reaction.

Fig. 4.--Mecbaniem of Oxidation-Reduction
of Pyridinenucleotide

'fheee two coenqmes play an essential role in some of the most

important oxidation reactions in the body.

Each reaction in which

they take pa.rt depends on a. protein enz1tne which ie specific tor

the su.bstrate being acted upon.

The protein combines with both

the coenzyme and the 1Ubstra.te.

The substrate is oxidized and the
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coeneyme reduced;

the protein remains unchanged •

.1 t7Pica.l example of such a reaotion is represented in the

oxidation ot trioaephospbate by diphoaphopyridinemicleotide.(Fig.
5)

In this case the origina.l substrate is bexoae-diphoaphate,

which is divided into two trioaepbospha.tea by enz)'ma'tic fission.
The aldoae form reacts with diphoephopyridinenucleotide in the

preaence ot a specific protein enz11De, resulting in reduced DPN
and phosphogl7ceric acid.

This is one of the important steps in

carbohydrate meta.boliam in the body.

The SJmbol 112 when

(Note:

,prefixing DPN or other enzJmes in the following f'igu.res indicates
the reduced form of the compound.)

0
II
C-OH

I

- - ~ H-C-OH

I

+ H2·DPN

H-y-O-P03H2.

H
Fig. 5.-Role of Diphoaphopyridinenuoleotide
in the Oxidation of Triosephospba.te
An interesting connection with vitamin

is now encountered.

Bi (thiamine

chloride)

!he phosphogl-yceric acid produced in the above

reaction ia rearranged enzymatically to phoephopyruvic acid.

Thia

ia then de-pho1pho17lated and the retul ting p7ra.vic acid is further

oxidized b7 means of' cocarbox7laae (diphoaphothiamine, the eesential
group of which is thiamine or :B1 ) to CO2 and ~0.
The coenzyme oxidation-reduction ie a reversible reaction,

but reduced coenzyme cannot be oxidized by air.

The reduced coenz:,me
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ia oxidized b1 fla.voprotein (the aBBential pa.rt of which ia riboflavin) f'ormin,i reduced flavoprotein, which in turn is oxidized
b7 the oxygen

ot air through the medium of cytochrome. (Fig. 6)

The same reaction 1e neceasary to oxidize reduced cocarbo:a:7laae to
1 ts active form.

Thus we see tbat three of the main components ot

the B-complex of vitallina, namel7, nieotinic acid, thiamine, and
riboflavin, are intimately concerned with each other in biological
oxidations.
•
HiDPN +FLAVOPROTEI N

- - - ~ DPN

t

+ H£fLAVOPROTEI N
I

H2:FLAVOPROTEIN +CYTOCHROME-~>FLAVOPROTEIN + HiCYTOCHROME

t

C~tochrome

H.:CYTOCHROME+Oz. . UXjaase

I

) CYTOCHROME+ Ha.Ca.

Fig. 6.--Mechaniem of BJdrogen Transfer and
the Re-oxidation of Carriers
The coenz7111es pla.7 a.n important part not onl:, in carbohJd,rate

metaboliem, a, indicated above, but also in protein metaboliem.
The reaction is essential.17 the same in this

oxidation of carboh7drate.

case as that tor the

!he amino group of the amino-acid ia

oxidized to an imi:no group, while the coenz1D19 is reduced.

Reoxi-

dation of the coenzyme again occurs aa described before, so that
it nay enter the reaction again.

Gluta.mic acid is the oa.17 amino-

acid thua far proved to be oxidised b7 coenz;yme.{56,57)
il though the aboTe statements suggest that the coenz7JD8s 4o

not need to be replaced since the7 ma.1 be uaed over and over ag&ln,

this is not the case;

tor some reason they are gradually depleted

in reacting, and nevr coenzyme mat be s111thesized from the various

components, especially the nicotinamide.

That auch s,nthesi s ac-

tually takes place wa.a first proved by Kohn and llein in 1939.
They showed that the content

·or

eozymase and of factor V i n ~

er7throc7tee was increased by the oral administration of nieotinic

acid in normal humans a.nd by the incubation of defibrina.ted blood
with nicotinic acid in yitro.(58) Vilter, Vilter, and Spies confirmed this 1n their work on pella.grins.

They also found that in-

jection of riboflavin into these patients caused a further marked
riee in the V factor of the erythrocyte•, above and be70nd tbat

produced

by

nicotinic acid alone.

They coneid.ered that riboflavin

probably assists in the aJD,thesie of the coenzymes fromnieotinic
acid. (46) Axelrod, Spies, and ElvehJem also found that administration of nicotinic acid to pellagrins caused a marked rise in the
coenzyme content of erythroc7tea and 1Dllacle.(45)
Although the two coenz,mes are so closely related chemically
and so identical in their mode of action, they react only in the
oxidation of certain specific substrates.

Triphoaphopyridinenuc-

leotide alone can act as the coenz1DJ8 in the oxidation of hexosemonopboepbate, citrate, and phosphohexonate.

Only diphoaphopyri-

dinenucleotide, on the other hand, can act a.a the coenz7Dl$ in the
oxidation of lactate, ma.late, beta-h7droqbutyrate, aldeh7d,e (mu~
aae), trioaephospha.te, gl7cerophosphate, and glyceraldehJde.

Either coenzJ1118 ia apparently effective in the oxidation of glucoae

35

or o.! glutamic acid in the liver.(56,57)

From the above discussion it is seen tbat nicotinie acid plays
a definitely-known role in body metabolism.

However, the manner

in which nicotinic acid protects the skin, gastro-intestinal tract,
mucous membrane,, and brain from daTeloping the le1ion1 seen in

pellagra is a.e yet unknown.

The final atoey of niootinic acid will

not be told until thia problem is solved.
The fate of excess nicotinic acid in the bod7was first investigated by .Ackermann in 1912. (59)

He found that the chief excretor,-

products of nicotinic acid were trigonelline, the methyl beta.1111 of
nicotinic acid, and nicotinuric acid, the dipeptide ot glycine and

nicotinic acid. (Fig. 7) Melnick, Robinson, and Field investigated
H
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Fig. 7.--Excretoey Products of
Nicotinic .Acid

the excretory products of nicotinic acid by feeding normal persona
large doses of nicotinic acid.

They found a great increase in the

•pyridine bodies" of the urine, mostly in the first hour after ingestion of the nicotinic acid, grad:ually decreasing in the next
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three houra.

Of this increased excretion of pyridine compound,,

51~ was trigonelline, 3rJ/, nicotinuric acid, and l~ free nicotinic
acid.(60)
.Uthough nicotinic acid has been defini tel7 proved to be a.

nece1sa.r7 factor f'or proper nutrition in the bwna.n, the dog(l7),
the pig(61), and the monke7(62), no one baa 7et. worked out definitely
the actual quantitative requirements for any of these species.

It

has been proved tbat aheep(63) and ra.te(64) do not need nicotinic
acid in their diet, for they are able to s111the8ize this factor b7
some aa 7et unknown means.
It is known, however, that·.

,he requirement for nicotinic acid

ia increaaed by anything increaaing carboqdrate metabolism, probabl7 through accelerated depletion of eoenz,mes.

Factor• causing

such an increased need would be pregnancy, acute b1'perth7r<>idiam,
fever, excess physical exertion, maintenance on intravenous glucose
for many days, or sudden adding of large inerem9D:ta of earboqdratea
and insulin to a diabetic diet.

The requirement would also be ilr

creaaed by any condition causing faulty absorption ot nicotinic
acid, as vomiting, diarrhea, acblorhydria, or ede• of the gaatro-

inteatinal

!DQIOs&

obstruction.

due to cardiac failure, renal damage, or portal

Faulty utilization of nicotinic acid, as in portal

cirrhosis, fatty degeneration of the liver, or pasaive congestion

ot the live; would likewiae increase the requirement of the individual for nicotinic acid.(74)
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PHABMACOLOGY AND TOXICITY

Since nieotinic acid is being uaed very extensivel1 in

the~

ap;r, it is desirable to know ·something of the actions of the drug
on the bod7 function• and also 1 ts toxic effects, if any.

Cben,

Rose, and Robbins investigated the toxicity of nicotinic acid aoon

after it was first used in the treatment of human pellagra.

i'b.87

found the MLD for rats and guinea pigs to be about 3.5 to 4.5 grama
per kilogram of body weight.

The7 also found that oral adminiltra-

tion of 2 grams of nicotini~ acid daily to dogs caused death or
severe illnees.

.Administration of leas than l gram was apparently

not harmful in 8J3.1' way.(65)
Some time later thma reported the reaul ta of hi• studies on

the effects of nicotinic acid on rate, chickens, and dogs.

Be

found no evidence of toxt., s;ymptoms during life or of pathological
changes post-mortem in &fJ.7 of the organs, although these animals

were f •cl as much as 2 grams of nico tinamide per kilogram bod7 weight
dail7 tor periods of up to two months.

There was no effect noted

on the metabolism, the circulatory ayatem, or the re1pirator7 17etem of normal animals given nicotinic acid or ita amide.

A alight

trandent riae in the blood pressure was thought to be due to the
acid pH of the aolution ueed. (66)

In treating pellagrina with nicotinic acid Fouts et al (18)
and Spies and hie aasociates (20) found that their patients experi-

enced 1en1at1on1 of heat, tingling, itching, and flulhi?li of the
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.........

_,
akin, eapeciall7 of the face and e:z:tN11itie1.
ai torr, however.

!he effect wu tran-

Spies and hie co-workers investigated theae ettects

more tboroughl7 and found that the administration ot 200 mgm. ot
nicotinic acid orall7 or of 10 mp. intraTenousl7 waa followed in
one minute by dilatation ot the auall vessels of the akin of the
face and upper trunk. . !he aubJecta complained ot heat, tluehiq,
burning,. and itching eenaationa.

There••• aome increased act1Tit7

ot the eebaceoua gland• and increaaed mot111 t7 ot the ga.stro-inte..
timl tract.

There wu no ettect on the blood pre1aure, reapira-

tor7 depth or rate, pulae rate or rhJtlqm, or the electrocard.io-

graphic record.

The•• worker• felt

that nicot1nio acid hat a weak

hiatamine-like aotion.(67)

Scat:tidi (68) and Card.in (69) ha.Te found that nicotin1c a4t4
cauaea increaaed tontp and inoreaaed contractions of iaolated por-

tion• ot etomach and intestine ot ga.inea piga and rabbi ta.

Thia

effect ia enhanced b7 atropine, (68) but it is not produced. b7 the
uae of nico t1UM4e or ao41um nico t uaate. ( 69)
SJd,enstriker et al found in treating pellagrina •1th nicotinic
acid that there • •

an

increa1e in -the aecretion ot gastric h1dro-

ehloric acid, even in some caaea ot -hlorhJd.ria.

fhe7 confirmed.

thia effect b7 g1Ylng Dicotinic acid to normal persons with a re-

•ultant i!lcrease in the ga•tric acidity.(70) Malagussi an4 h1a
co-woJtbra stated that injection of nicotinic acid into :normal pel"aona produced ae gJ'IMI' a riee in gastric hydrochloric acid aa did
.

~

the inJection of hiatam&De

but

f&iiad to give r1 .. to 8!1J7 IMC19tion
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of acid in cases with complete achylia.(71)
Moore proved by means of exposing the blood vessels of the
spinal canal and of the bra.in in laboratory animals and by measur-

ing the intraspinal fluid pressure on humans tba.t nicotinic acid
caused vasodilatation of the brain and spinal cord, as well as of
the skin. (72)
:Bean and Spies have reported tba t ad.di tions to the pyridine

ring of nicotinic acid or removal or aminization of the carboxyl
group ma.de the aubsta.nce inert as a vasodilator.

Food taken just

before the nicotinic acid also prevented its unfavorable vasodilating effect.

These workers suggest that repeated small doses of

nicotinic acid or use of acme derivative of nicotinic acid will

eliminate any unpleasant side effects.(73)
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CLINICAL USES

In

Pellagra
•Pellagra is a disease entity cba.raeterized pathologically b7

an er7thematoua, pigmented,

&lld. exf'oliative derma.titia; atomatitia;

glosaitia; gaatro-enteritis; hepatitis; proctit1a; urethritia and
vaginitia; and clinical.17 b7 the subjective a,mptom •Jndrome con.-

siat1ng of burning (•scalded•) aenaation in the mouth and tongue,

anorexia, diarrhea, burning in anal region and in the urethra, or
T&gina; T&ried nervous manifeatationa; emaciation. cachexia, and

T&.rying degrees of anemia from the mild aeconda.:r:7 t7Pe to the blood
picture of eevere primary anemia. •(4)

.

The claes1cal triad of 17DlPtoms in pellagra. is dermati tie,

diarrhea, and dementia.

However, all of these need not be present

in ever7 case of pellagra.

Jlthough the dermatitia ia considered

especiall7 characteristic, many case, have been reported with no
altin lesions demonetrabl~, the so-called 12ellagra .lial. pellagra.
SJdenstriker deacribea two main types of pellaara, one a reeul t ot lG19-continued mild deficiency, the other the result of a
severe, rapid depletion of nicotinic acid (ae in severe alcoholiem
or in maintenance for long periods on intravenous glucose). In the
chronic partial defic1enc7 the first a119toma are u81l.&ll7 milclt
peJ"Chic disturbances.

Bext vagu.e gastrc-inteatinal disturbances

with anorexia. a.!ld mild gloesi tis make their appearance.

A.a this

continues we get achlorh7dria., diarrhea, and more severe psychic
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di1turbance1.

Dermatitia ma.1 appear at &ll1' time.

!he patient may

get intection, in the mouth, Y&gim, rectim, or e1ophagua aa a reaul t ot the lowering of the cellular deten• mecbani •••

Fi1l&l.l7

we get delirium, stupor, dementia, or an encephalopathic aynd.rome.
In seYere case• there •7 be irreveraible chu.gee in the gastrointeatinal mu.coaa and in the brain (with-permanent dementia).

In

the aevere rapid deficienc7 we find marked psychic diaturbancea,

severe gloaa1tia Cotten accompanied b7 infection with Vincent•,
organiema or fungi), and. occaaionall7 bulloua or mcrotising 4erm-

ati Ua. (?4)
~

Thia diaeaae was once Ter7 d1:tfiC1;1.1 t to cure.

ar7 treatment

had.

.&lthough 41et-

been uaed almost since the time of Caaal'• tirat

deacript1on of pellagra, the prognosis in most caaes waa poor, and.
mortality rates~ especia.117 in inatitutiona, were :teartull7 high.
However, since BlTehJem'• discovery that nicotinic acid was the
pella.gra-prevent1Te factor in 1937, reports of almoet miraculoua

cu.rea ot all typea of pellagra 1:r nicotinic acid have been publ11hed,
and the mortality r&te from this di1eaae baa dropped 1teac1111 to

ver7 low figurea.

J'outa et al (18), I 8m1 th, RQ.tfin, ar>.cl Sm1 th (19),

Spies and h11 aaeocia.tea (20,67), and S7d,enatr1ker and hie co-work;.

era (70) reported cure, of large zm.mbera of cases of human pellagra
within a f • months after J:lTehjem•s original report waa po.blishecl.
Since t:b&t time imrmnerable repo rte of cure• ot pellagra b7 u1ing

nicoUnic acid or aome of 1 ts der1vat1 ••• have been publiahed..
The amount of m.cotim.c acid necessary for tbe cure of pellagra
\_,.

ha1

not been eata.bliahed.

with good renl

t,. (18)

route and co-worker,

UNcl

500 mgm. 4&117

S1d,enatrilr.er recommend.a from 300 to 1800

mgm. of nicotinic acid 4&117 depenling on the 1everit7 of the con-

di tion, with decrease to 100 to 150 mgm. da1l7 after improvement
11 1een. (74)

From all report, it appears that at present the beat
\

guide in therap;y ie the clinical ooDdition of the patient.

'fherap7

should not be .topped 'because of the transi torr unpleaaant effects
ot flulhing, tingling, or burning ot the lk1n.
,

!he fact that all 1,mptoms ma.7 not be relieved. b;y nicotinic

acid alone brtaga out the connection of pellagra with d.eficienc7

ot other

Yi tamine, u

etreased by al.moat all authora.

It baa been

auggeated, because ot thie tact, that all patients receiYe large

doeea ot all vitamins, eapeciall7 the B-vitamine, a, well as a h.ighcaloric, well-rounded diet.

Liver or liver extracts have been ea-

peciall7 recommended for such a.p\lrpoae.(4)
Elvehjem baa stated that nicotinic acid should be u1ed in the
treatment of pellagra 1olel7 aa an emergenc1 meaRre.
basic cause of the condition

tl 6ietary,

he

Since tbe

eugg••"- for

permanent

cure, correction of the diet b1 un of proper toed.a, high in. Yi tamine, proteins, and otber essential elements.

Speci&l care am.et

be u1ed in area, where pellaara 1 a endemic to provide die ta high

in nicotinic acid.(75)

Ip

Gaatro-1nteat1p&1Jl.lltder1
Although it ha• _long been known that gaatro-inteatinal patholo17

43

e:d1t1 in pellagra. it • • been onl.7 within the pa.it twent7 79ar1

or ao that a concept haa ariaen sugeeting that pellagra ma7 actuall7
be a. reault rather tbaa a cause of gaatro-inteatiu.l patholoa in
The tirat report ot pellagra.following . .tabliahed.

m&DT caaea.

preceding patholoa ot the ga.atro-inteatinal tract waa that ot Rolph

in 1916, who reported claaaical pellagra in a woman with carcino•

of the atoma.ch. (76)

In 1925 Jo70e am Sea~rook reported a caae of

pellagra following the deTelopment of atricture of the rechia. (77).

In 1926 1 1 Lear7 tirat nggeated. the term •aecondaey pellagra•
to claot, caaea of pellagra following organic patholog7 of the p.etn-inteatill&l tract.

He reported Nver&l caeea of pellagra in

patients with obetzucting lesions of the eto:mach or inte1t1ne. (78).
Ca.see of pellagra developing in patient, with ulcerative colitia

were reported b7 Ba.mes in 1926 (79) and b7 Jankelaon and llcClure

in 1940. (80)

I11 Barae1 1 case the patient wa, actual.17 under bee-

pi tal care with a high-caloric, low-residue diet at the ti• pellagra 4eveloped.

!urner reported 25 caaee of 18con4ary pellagra in 1929.

toum t:b&t

Be

theH compriae4 about 2~ ot all pellagra caeea eeen.

:S7 far the greateat zmmber of e&18a were eeconda17 to rectal atric-

tun.

Otberil had gaatric carcino•, ulcerative colitis, and sev-

.

eral otmr miecellaneou1 organic 41aor4er,.

Several ot the•• pa-

tient, ha4 been on. what waa cona14ered a4equate diets betore tbe7

4evelope4 pellagra.(81) !ha.7aen reviewed the literature on 1ecoDAary pellagra in 1932 and. found that moat e&1e1 were cauaed b7 ateno1i•

ot the digeati n

tract, with the 1:16Zt moat frequent cauae being

alternating diarrbea and conatipation, and the next moat coJIIDOn
cau.ae diarrheaalone. (82)
!here h&a been a good deal of work done on the occurrence of

achlor:tqd.ria in pellagra.
the C&Ms

ba4

!'hafaen finds in hie reTiew that -8~ of

low or abeent gaetric ac14.(82)

S74enetriker report•

complete achlor:tqd.ria 1n abo12.t ~ of hie caeee, with low gaatric
aciditJ in al.moat all of the remaining • • (81)

!omma.1ee report,

the gaatric ac141 t7 ae being below normal in all C&Na of pellagrou•

ehild.ren atwlie4. (8') Diaz-Jlubio reports in 1tud7ing 342 ca•• of
pellagra that 9~ showed no tree acid &1'l4 low total acid, 7'11, had.

blood, 75'/, u.4 lactic acid, 8Z3.d. 401, ha4 large ame>UDta of mu.cv.e in

the ga.1,ric contente.(85)
.After n1cot1nic acid waa ahown to be the pellagra-preTentiTe

factor, the responee ot caaea nch aa tho•• deacri,ed abov-e te th1•
compo'Qlld wa.a 1nv-eet1gated.

In 1938 Ban.seen reported that a ca..

of pellagra occurring ais months after 1Ub-total gaetric reeection
wa• treated su.cce1stull7with campolon (a liTer extract).(86)

In

1939 Kaeeen reported a caae ot pellagra eecondar7 to gaetro-enteroato1111 which waa not ~tected by liver extract and B1 , d.iet, or
other treatment, but ~epond.ecl promptl7 to the

ac14.(8?) 87den1tr1lter (70), !omma1eo (84),

UN

of m.cot1D1c

an.cl D1az-lta.bio(85),

1howed that nieotinic acid increased the gastric aecretion in pell-

agrina, even in • • ca.sea of complete achlorhydria.

K&laguzsi,

howev-er, reported that al though the atrophic gloaai tia wae improved.
I
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in complete a.eh7lia cases, there was no rise in the gastric acid
after tbe administration of n1cei,1n1c acid.

However, these were

not pellagroua achlor}qdria. caaea.(11)

Thlre ha• not been much investigation on the effect of nico-

tinic acid on the gastro-inteatinal function, aside from that on
the effect on the secretion of gastric acid.

Crar.ulall, Cheele7,

Haneen, and Dunbar found definite chailges in the gaatro-inteetinal
tract ot dogs on a ~&Ck to~e-producing diet b7 the uae ot J;.ra.7

atud.ie1.

They found firat l',qpermotilit7 (appearing in about three

to f 1ve weeks);

then areas of a tonic bowel, with •pu.4411.ng• ot

the barium in these

o beerve4.

area.a, and gas in the amall inteetine were next

The large bowel was leaat suacepti ble to these change a',

but eventua.117 the entire gastro-·1nteat1138.l tract was affected.
~e.. changes all appeared before an7 signs of black tongue could

be discerned in all but one dog. (88)

In 1940 Jean and Spies found,

b7 means of tluoroacopic studies on hmaana, that

nicotinic acid

caueed increased perietalaia of the intestinal tract, with greater

tonne and greater contraction waves than before the injection of
the brlg.(89)

Some very interesting experiments have been carried out by

,-tri, Jlffrgaard, and Bandier on p1ga.

The7 have performed total

gaatrectom1es on several groups of jigs.
were placed on different diet,.

After recover7 these groups

Some were given nicotinic acid;

eome were deprived of this aubatance in their diet; others were
given various vi tamine, alone or in combination, with their diet.
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.lll aroy;pa deYeloped pig pellagra in about the aame time--6! monthl

atter ga.1trectom7.

Jurthermore, the T&rioua Ti ta.mine, includ.ing

nicoth.ic acid, had no effect even if giTen parenterall7.

!he ob-

vioua conclulion, therefore, is that some gastric fUDC:tion 11 nec-

••1&17 tor the preyention ot pellagra in piga.
tor or fiimct1on Sa has not been aacer'tained.

Ju.et what this fac-

Whether some aim1lar

meehani am ia nece sau7 in other animel • an4 lmmana 1 e al eo 'tmlmown,

but i».ftatigaiioa of the 1ubJect would cert&1nl7 be worth-while.
(90-91)

!here have been report• of the uae of ni~tinic acid in gaatro-

inte1t 1nal patholoa excluaiTe ot that a.asociated. with definite
pellagra.

Bing and. Broager (9~) and. J'a.cha an4 WiaNlinck (93) re-

port iq,rovement of 1evera.l caeea of. epru.e on trea\111:nt with nico-

tinio ac14 alone.

81eclek and lnH report a can of •••r• 41arrhe&

reaembl1ng aprv.e in which the diarrhea was controlled and the etoole

became tat-free on treat•nt with nicoti~ide. (94) '!ea1le7 report•
~he clramatic cure of NTeral c••• of

nmer diarrhea of the n.on-

infectioue t7Pe 1n infant• with· no other medication than vi tamine,
eapeciall7 nicotinic acid.. (95)

Sp1ea et al report Hver&l c••••

of conatipation without pellagra in which normal tunction returaed.
after treatment with nicotinic acid.

Some otur ca••• of the . . .

group, however, failed to reapond to thia treatment. (67)

Boraook and hie aaaociates reported. a Yer7 large eerie• of
pat1eata with 1aatro-inteatinal complaints without demonatrable
organic leeione who were relieYed of their •J'ID.Ptome b7 the uee 0-t

B-complex vi tamina 1n the form of rice-poliahing concentrate or
apeci&l wheat cereal, where merel7 adequate dietary regime had failed.

There were no signs ot beri-beri or pellagra in any of these case,.
(96)

Che1le7, Dunbar, &ll4 Crand.all alao report a large eeriea ot

caeee with gaetro-inteatinal complaints (chiefly flatulence, altel'-

nate conatipation and diarrhea, and abdominal diatre11) in.whom no
organic leaion could be found.

Whole vitamin B complex or•nicot1nic

acid alone relieved the •JmPtoms, whereas thiamine and. riboflavin
alone failed to do ao.

!b.eae workers au.ggest better response to

whole B-complex than to nicotinic acid alone, howeYer. (97)

J'rom the above diacuaaion 1 t can be readil7 ••n that the roleQ
Dicotinic acid ia to pla7 1n treatment of gaatro-inteatinal diae&••

1a tar from being established.

For the moat part the 11 terature

contains unrelated reports, moat of which are unconfirmed, ao that
no cl~ar picture of the whole eubject can 7et be drawn.

!n thi1

field of nicotinic acid therap7 thorough inveatigation ia incleecl
aorel7 neeud.

Ia lfllfllpg1ca1 »111a111
Mental 11Dl1)toma have been known to be a part of the pellagra ,

•Jndrome 1ince the earliest recognition ot the d.iaeaee.

Some in-

teresting name, which have been given to pellagra b7 the Spam.ah

and the Italian peaaants in the past bring out this tact.
ea1e haa been called

maJ. clel higado (diseaae of

The d11-

madne1&), al,

a;pi&M (diaeaae of melancholia), and galore ill

tegato (the

della

heat

or tever of madne1e).

More red.entl7 Italia:o. ph7aician1 have called

1t pm;hpneuro1i1 mai4ica ( the p110honeuroaia of corn or maize). (98)
I

In 1913 Singer and 'Pollock investigated the central nervoua
17atem patholo11 1n pellagra

••rr

thorough].:,.

They

found. in the

acute attack of pellagra a picture of •cen.tral neurit11•, aa aeen
in general intoxications~

!here waa

al10

chromatol71ia of neuron,,

1atellito11a, aatroc7to1ia, preaence of amebo14 glial cells, 8Zld.
mo4erate peri T&acul.ar infiltration.

In chronic c&Ne tha7 found

in the central nenoua a71tem tatty and fibrinoid depuration,
chronic lf111l bocl.J changes in the cells, destruction of nene fibera,
incre&ae of glial fibers, but no vaacular changes. (99)
Spies et al reported in 1938 that the mental aymptome of pell-

agra were un.al.17 of the ao-.called neurotic' tn>•, especiall7 what
11 cla11ed as neurasthenia, characterized. bT laasitud.e, palpitation,

n=bn•••,

fatigue, and other Tague a71D.Ptom1.

So• patients showed

delueiona, dieorientation, depresai6n, or memor7

1011.

.All mental

aJIIIJ)toma were cured promptly by the uae of nicotinic acid.(100)
llatthew'a reported nailar ca••• with the aame results at about the
ea.me time.

He mention, deludona, halluc1nat1ona, w!th 1omet1me1

depreaaion and even atupor· a.a the moat common e,mptome in hie
patient a. (101)
Yroatig and Spies re-inveatigated the mental •J'III.Ptome associ-

ated witb pellagra in 194.0 and suggested that the initial nervou1
1Jmptom1 were general h7Pereathesia, increased p97Cho-motor drive,

fatigo.abilit7 au4 wearineae, head.ache,, and 1leeple1sne11.

In

general the7 report that the picture is one

of

an anxiet7 state

· with depreseion. · .Although 1,mptoms are cured promptl7 w1 th nicotinic acid alone, these authors auggeat a well-balanced diet be

given as well.(102)
S7d,enetr1ker and his associates were the first to attribute
certain mental e7JDPtoma to nicot1n1c acid deficienc1when none ot
the u8\l&l aipe ot pellagra were present'.

The caaea reported un-

al,.17 ahowecl 1tupor or clouding ot con1ciou1ness.

Some caee1 eh.owed

irrational behavior, delusions, diaorieuation, and other signs ot.
what is

uauall7 called toxic p170hoeis or exhaustion delirium.

.All

cases improved on treatment with nicotinic acid al though some fflff

required do16a of over 1000 mgm. daily.

.ill but a few cases were

com,pletel7 eured.(103,104)
More recentl7 Jolliffe &lld hi• eo-workera have reported 150
ca.sea

of an encepbalopathic sJ'?l,drome ch&racteri zed b7 cloucl.ing ot

con1ciou.snes1, cog-wheel rigidities, and uncontrollable graaping
and aucking reflexes.

On

a treatment of h7drat1on alone or h7dra-

tion p1'1.a thiamine cbloride, $5 to 1~ died; on a treatment of
h7drat1on plua whole vitamin B complex there wa1 a drop in mortal1t7 to 6~; but on h7d.ration plus nicotinic acid al.one the mortal1 t7 dropped to 3~, and since moat of theae cases diei of some ia-

tercurreat infection, the •corrected mortalitr' on nicotinic acid
therapy waa about 14~.

These workers call the a,ndrome •nicotinic

acid deficienc:, encephalopathy" on the basis of these f1n41nga.
:N'o aigna ot pellagra were present in the group of patient,. (105,106)

se

• ot

nioa.tinic acid in neurological clieorders inclucle

ta alcoholic apd.romea.

llainzer and Xrauae reported

ot delirium tremene w1 th nicotinic acid where thiahad failed.

'!hie patient also had some atoma.ti tie,

vomiUq, an4 altemate diarrhea and constipation. (107) lla7 reported.
the cure of f ur caaea of alcoholic p1,choai1 b7 g1Ying 600 mgm.

ot

4&117.(108) Moat 11911rolog1ats feel that niootu,.1~
aci4 ahould

given along with .thiamine ohlo ride in. the T&rin.e

f the ~ae of nicotinic acid in motor tr-.ct inYolTemente are not ver7 muneroua.

Blankenhorn reported cure of two caae,

ly•i• with pellagroua signs following alcohol ad.d.ic-

ot 'br••r'• 19aat and a diet high in calories, vit-

amins, and p

(The treat•nt wa1 carried out in 1937, before
had been 1dent1!1ed aa the •P-P factor•). (109)

Moore

reported nar. 4 improvement in tiYe cases ot ma.ltiple eclero1ia on
nicotinic acid and thiamine.

fect to the

He attributed the ef-

sodil&ting action of nicot1n1c acid on the veaaele

nervoue 17atem, euoh ae occurs in f'eYer therap7,
uaed eucceeefull7 in multiple 1elero1i1.(72)

•
!hen ha • been eo man7 different miaoellaneous ue• euggeeted

to~ nicotinio acid ia the literature that it ia difficult to eM
how all of t

m can be valid.

Onl7 thoH which have been fairl7

well accepted will be mentioned.
!he uae of nicotinic acid in Vincent I a angina was tir1t au.g-

ge1ted b7 the eon,tant presence of stomatitia in pellagra.

In 1939

Mo rria and J'ranltlin reported improvement in doge nttering from
tuao-apirochetal atomat1t1a after the a4min11tration ot nicotinic
acid. (110)

Xing reported cure ot tour mm&U cases ot severe ulcer-

at ion ot the mouth a11ociated with the proved preeence ot Vincent'•
!his cu.re was accomplished 1olel7 b7 the ad-

a}'ID'b1ot1c organi11D1.

m~iatration of rdcotinic acid with no local treatment.(111)
Barria and Moore (112) and. .ltkinaoa (113) have reported det1ni te improvement of symptoms in patient• with Mcie re' a a711drome

on t.reat•nt with nicotinic acid, either alone or combined with
thiamine.

These caeea had. no clo aure of the J:uatachia:n tube

no intralabyrinthine hemorrhage aa the basis tor their

am.

a7Bdrome.

Caaea with auch etiologic tactora could not be 8%p8Cted to reapozid
to nicotim.c acid. (112)

The reeul ts were attributed to the vaao-

dilatiJ>g action ot the nicotinic acid.

Young patients ehowed the

moat improvement. (113)

lfwneroua other u.aea of nicotinic acid have been reported. Saphir
reported prompt cure of xero1tomia with nicotinic acid plus Je&at
and thiamine, whereas the treatment wa.e not aucceBStul with onl7

' • la1t two. (114)

Gral3am reported marked alleviation of 1Jmptoma

of radiation sicltneaa b7 the uae ot nicotinic ac14.(115)

Selfridge

ha.a reported success in the treatment of higb-toM d.e&fm11 with

nicotinic acid.. (116) Moat of tbeee reported uee1 ot nicot1nic acid
require further 1nveet1gat1on before definite conolu1ion1 ma.7 be drawn.

SUIOWlY ilD CONCLUSIONS

There aeema to be no division of opinion about the etticac7

of nicoiinic acid in the treatment ot pellagra.
been made

Sugge1t1ona have

b7 moat author,, however, that other vitamins,

eapecial17

of tbe B complex, mat also be supplied. for mazillWll curative effect.
J'urthermore, correction of diet&r7 factors to pre'V9llt tbs disease

or relapaea 1 a considered ea1ential •

.A.a to the other uae1 of nicot1n1c acid there 1 a m real
, con1enn1 of opinion.

However, moat pa7Chiatriat1 recommend 1 ta u.ae

with thiamine chloride in the va.riou, toxic paJCbD••, e1peciall7
thoae ot alcoholic origin.

Use ot tbe drug in vague ga8'ro-1nteaUn-

al complaint, in peculiar DeUro-pa,chiatric 17J1drome1, and 1n varioua
miecellaneoue .condition• ia still questionable a.?ld m.at remain eo

· until a greater maaa ot reports is available.
Chemical d1apoa1a of nicotinic acid deficienc7 11 at present

unaat1afactor7, al though there are aeveral pod method.• whtch could.
be

U88d

clinicall7 if au.itable criteria can be worked out •

.la ha.a been stated in the bod7 of thi1 paper, although the

role of nicotinic acid in biological oxidationa ia known, Ue mum.er
of protectiq the akin, mucoue membranes, gaatro-inteatinal tract,
and central nervoua 1y1tem ia atill unknown, and until we do know
1ometh1q of thi• act1Tit7, we can not uae nicotinic acid to ita

greate1t ad.vantage in the practice ot medicine.
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